Antibiotic-Resistant Organisms (AROs) and Clostridium difficile Infection (Archived)
Activity
Large Group Session
Large Group Session
- Indicates most relevant
Objectives
Activity Objectives
- To be familiar with the definitions, causes, and adverse effects of AROs.
- To be able to describe the epidemiology, clinical presentation, diagnosis, management, and prevention of the following organisms: Methicillin-resistant Staphylococcus aureus (MRSA); Vancomycin-resistant enterococci (VRE); Multi-drug resistant Gram negative bacilli; Clostridium difficile
General Objectives
Tags
Archived
Archived
Basic Sciences
Epidemiology
Microbiology
Prevention and control
Discipline
Infectious Diseases
Microbiology
Public health
MeSH
Anti-Bacterial Agents [D27.505.954.122.085]
Antimicrobial Stewardship [N04.761.879.300.500]
Clostridium difficile [B03.300.390.400.200.250]
Clostridium Infections [C01.252.410.222]
Disease Outbreaks [N06.850.290]
Drug Resistance, Bacterial [G06.099.225]
Drug Resistance, Microbial [G06.225]
Drug Resistance, Multiple, Bacterial [G06.099.225.812]
Methicillin Resistance [G06.099.225.500.600.525]
Methicillin-Resistant Staphylococcus aureus [B03.300.390.400.800.750.100.500]
Vancomycin Resistance [G06.099.225.984]
Vancomycin-Resistant Enterococci [B03.510.550.250.250.650]
